Dr. Francis Collins has retired from the U.S. National Institutes of Health (NIH). At the IBM Center for The Business of Government, we have had the privilege of chronicling his journey through interviews, profiles, and in-depth reports.
After more than three decades of public service, Dr. Francis Collins has retired from the U.S. National Institutes of Health (NIH). His career stands as a testament to the power of visionary leadership, scientific curiosity, and a relentless commitment to advancing medical research. From decoding the human genome to steering the NIH through unprecedented challenges, Dr. Collins has left an mark at the intersection of science, medicine, and public service. At the IBM Center for The Business of Government, we have had the privilege of chronicling his journey through interviews, profiles, and in-depth reports. As we reflect on his legacy, we draw upon these works—including a 2012 interview on The Business of Government Hour, a profile in The Business of Government magazine, and two seminal reports by Professor W. Henry (Harry) Lambright—to recognize and highlight his contributions.
Dr. Collins’ public service career is perhaps best encapsulated by his leadership of the Human Genome Project (HGP), one of the most ambitious scientific endeavors in history. Appointed Director of the National Human Genome Research Institute (NHGRI) in 1993, he guided this international collaboration to map the entire human genome, a feat completed in 2003. This monumental achievement revolutionized biology and medicine, unlocking new frontiers in personalized healthcare and disease prevention.
In Managing “Big Science”: A Case Study of the Human Genome Project, authored by Professor Harry Lambright for the IBM Center, Dr. Collins’ role as a scientific and managerial trailblazer comes into sharp focus. Lambright details how Collins navigated the complexities of coordinating thousands of scientists across multiple countries, managing a multi-billion-dollar budget, and balancing political pressures—all while keeping the project on track. His ability to foster collaboration and maintain a clear vision for the HGP’s potential set a gold standard for leading large-scale scientific initiatives. Lambright notes that Collins’ success stemmed not just from his scientific acumen, but from his skill in aligning diverse stakeholders around a shared mission—a hallmark of effective public administration.
In 2009, Dr. Collins was appointed NIH Director, a role he held until his retirement in 2021. Over his 12-year tenure—the longest of any NIH Director in over half a century—he oversaw a budget of more than $40 billion annually and guided the agency through a period of rapid scientific advancement and societal upheaval. His leadership touched on everything from the BRAIN Initiative to accelerate neuroscience research, to the All of Us Research Program, which aims to build a diverse health database for precision medicine.
The IBM Center’s second report by Professor Lambright, Forging Governmental Change: Lessons from Transformations Led by Robert Gates of DOD and Francis Collins of NIH, offers a comparative lens on Collins’ leadership. Paired with former Defense Secretary Robert Gates, Collins emerges as a change agent who modernized the NIH to meet 21st-century demands. Lambright highlights how Collins championed data-sharing, interdisciplinary research, and public-private partnerships, transforming the NIH into a more agile and innovative institution. His ability to adapt the agency’s structure and culture while maintaining its core mission mirrors the qualities of a master strategist—qualities that Lambright argues are essential for leading government organizations through turbulent times.
In 2012, Dr. Collins joined host Michael J. Keegan on The Business of Government Hour, a radio program produced by the IBM Center. The conversation revealed the man behind the science—a leader deeply committed to both discovery and service. Dr. Collins spoke passionately about the NIH’s role in translating research into tangible benefits for patients, emphasizing the importance of collaboration between government, academia, and industry. He also shared his approach to leadership: fostering a culture of creativity, encouraging risk-taking in pursuit of breakthroughs, and ensuring that science serves the public good. His optimism shone through, offering listeners a glimpse into the passion that guided his career.
This interview, preserved as a resource by the IBM Center, underscores Dr. Collins’ ability to communicate complex ideas with clarity and inspire trust—a rare combination that amplified his impact as a public servant.
The IBM Center also featured Dr. Collins in The Business of Government magazine, where we explored his career trajectory and philosophy. The profile painted a picture of a scientist-public servant who adeptly bridged the worlds of research and policy. It highlighted his early work as a physician-geneticist, his discovery of genes linked to diseases like cystic fibrosis, and his rise to prominence as a leader who could unite disparate communities—scientists, lawmakers, and the public—around a common purpose. The piece celebrated his knack for turning scientific potential into actionable outcomes, a thread that runs through his entire career.
Dr. Collins’ retirement marks the end of an era, but his influence will endure. The tools and knowledge he helped create—most notably the human genome sequence—continue to drive breakthroughs in cancer treatment, rare disease diagnosis, and beyond. His tenure at the NIH strengthened the agency’s role as a leader in biomedical research, even as he navigated challenges like budget constraints, political polarization, and the COVID-19 pandemic.
Through the IBM Center’s lens, we see Dr. Collins not just as a scientist, but as a master of "big science" governance. His story, as told in Lambright’s reports, our magazine profile, and the 2012 interview, offers timeless lessons for public leaders: the importance of vision, the power of collaboration, and the courage to embrace change.
As we bid farewell to Dr. Collins’ extraordinary public service career, we at the IBM Center for The Business of Government extend our gratitude for his contributions—and for the chance to document his journey. His legacy reminds us that the intersection of science and government, when led with purpose and integrity, can impact us all.